This web conference was a part of the IAPP European Data Protection Intensive Online 2021.
Original broadcast date: April 1, 2021
Is a pandemic reason enough to roll out surveillance? Our panel is ready to answer your burning questions regarding the impact COVID-19 is having on privacy. Join us to explore how health companies are processing sensitive data and how telemedicine is shaping the future. We will cover how businesses have handled additional sensitive data during this crisis (including article 9(h) and (g) of the GDPR) and debate what is safe and what is intrusive. This interactive session includes a travel industry test case and firsthand account from the insurance sector. We will analyze what impact COVID-19 has had on companies from a business, employment and cybersecurity perspective.
Dave Cohen, CIPP/E, CIPP/US, Knowledge Manager, IAPP
Marta Dunphy-Moriel, CIPP/E, Partner, Deloitte Legal
Adrian Murray, Partner, Brand Murray Fuller, General Counsel, 4D Pharma
Tünde Sátorová, CIPP/E, EU Data Protection Counsel, Veeva
Jacobin Zorin, CIPP/E, CIPP/US, CIPM, FIP, CPO, Cepheid and Danaher Diagnostics Platform, Cepheid/Danaher